Shriprasad R. Deshpande
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Shriprasad R. Deshpande has a total of 287 co-authors. Here are the top co-authors by number of shared publications:
Kevin O Maher
Children’s Healthcare of Atlanta, Atlanta, GA, USA
7 shared publicationsKevin O. Maher
Department of Pediatrics, Division of Cardiology, Emory University School of Medicine, Children’s Healthcare of Atlanta, Atlanta, GA, USA
6 shared publicationsBahaaldin Alsoufi
Department of Cardiothoracic Surgery, Norton Children's Hospital University of Louisville Louisville Kentucky USA
5 shared publicationsPranava Sinha
Department of Pediatric Cardiovascular Surgery University of Minnesota Minneapolis Minnesota USA
5 shared publications- Bibhuti Bhusan Das
Methodist Children’s Hospital
4 shared publications Can Yerebakan
Division of Cardiothoracic Surgery, Children’s National Hospital, Washington, DC, USA
4 shared publications
Latest Publications
- Open Access
- 25 March 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (3) , 502-508
A 10-year single-centre report on Fontan attrition and non-Fontan candidacy
Background: As patients progress through single-ventricle palliation, changing haemodynamics and patient conditions can prevent progression to Fontan. We sought to determine the incidence of Fontan completion at our institution and to investigate the reasons for non-Fontan candidacy. Methods: Patients who underwent superior cavopulmonary anastomosis from 2010 to 2020 at a single institution were included. Pre-Fontan testing was reviewed for all patients, and the primary reason for non-candidacy was determined based on a review of the electronic medical records. Results: Of the 427 patients included, 396 (93%) underwent Fontan or were referred for Fontan at the time of the study. Reasons for non-Fontan candidacy in the remaining 31 patients included cardiac reasons ( n = 26), mainly univentricular dysfunction or atrioventricular valve regurgitation, respiratory conditions ( n = 3), or miscellaneous reasons ( n = 2). The patients who were non-Fontan candidates due to respiratory conditions and miscellaneous reasons are all alive without further palliation at the time of the study. There are 17 patients (17/31; 55%) in the non-candidacy group who had a heart transplant or were listed for transplant at the time of the study. Non-Fontan candidates had a higher incidence of moderate or severe atrioventricular valve regurgitation prior to superior cavopulmonary anastomosis. Discussion: Thirty-one patients (31/427; 7%) were not Fontan candidates at our centre. Our results demonstrate that the reasons for non-Fontan candidacy after completion of stage 2 are broadly due to echocardiographic findings and respiratory concerns. Predicting non-Fontan candidacy prior to superior cavopulmonary anastomosis remains difficult.
- 25 March 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (3) , 502-508
Open AccessA 10-year single-centre report on Fontan attrition and non-Fontan candidacy
Background: As patients progress through single-ventricle palliation, changing haemodynamics and patient conditions can prevent progression to Fontan. We sought to determine the incidence of Fontan completion at our institution and to investigate the reasons for non-Fontan candidacy. Methods: Patients who underwent superior cavopulmonary anastomosis from 2010 to 2020 at a single institution were included. Pre-Fontan testing was reviewed for all patients, and the primary reason for non-candidacy was determined based on a review of the electronic medical records. Results: Of the 427 patients included, 396 (93%) underwent Fontan or were referred for Fontan at the time of the study. Reasons for non-Fontan candidacy in the remaining 31 patients included cardiac reasons ( n = 26), mainly univentricular dysfunction or atrioventricular valve regurgitation, respiratory conditions ( n = 3), or miscellaneous reasons ( n = 2). The patients who were non-Fontan candidates due to respiratory conditions and miscellaneous reasons are all alive without further palliation at the time of the study. There are 17 patients (17/31; 55%) in the non-candidacy group who had a heart transplant or were listed for transplant at the time of the study. Non-Fontan candidates had a higher incidence of moderate or severe atrioventricular valve regurgitation prior to superior cavopulmonary anastomosis. Discussion: Thirty-one patients (31/427; 7%) were not Fontan candidates at our centre. Our results demonstrate that the reasons for non-Fontan candidacy after completion of stage 2 are broadly due to echocardiographic findings and respiratory concerns. Predicting non-Fontan candidacy prior to superior cavopulmonary anastomosis remains difficult.
- Top Cited Papers
- 10 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (6) , 382-395
Association of Pre-Fontan Hemodynamics With Long-Term Outcomes After Fontan Palliation: A Study From the Pediatric Cardiac Care Consortium
BACKGROUND: Long-term outcomes after Fontan vary widely. Although pre-Fontan hemodynamics predict early failure, their association with long-term outcomes remains unclear. We hypothesized that pre-Fontan hemodynamics predict long-term risk of death or transplantation. METHODS: We analyzed data from the Pediatric Cardiac Care Consortium, a US-based multicenter registry including patients undergoing first-time Fontan with pre-Fontan catheterization and long-term follow-up. Patients undergoing a Fontan procedure before 18 years of age at any time between 1982 and 2011 were included in the study. Outcomes of interest were in-hospital Fontan failure (death or takedown) and postdischarge death or transplantation, identified through matching with the National Death Index and the Organ Procurement and Transplantation Network through 2022. Associations between pre-Fontan hemodynamics and long-term risk for death or transplantation were assessed with Kaplan-Meier survival curves and extended Cox regression. RESULTS: Among 1175 patients (736 [62.6%] male, 626 [53.3%] with systemic left ventricle), 1111 were discharged with Fontan physiology. Over a median postdischarge follow-up of 20.6 years (interquartile range, 18.2–24.4 years), 85 deaths and 49 transplantations occurred. Pre-Fontan mean pulmonary arterial pressure was the strongest hemodynamic predictor of postdischarge outcomes with a continuous association and no clear inflection point; 25-year transplantation-free survival declined from 83.7% (95% CI, 77.6–88.3) in the low mean pulmonary arterial pressure tertile to 73.7% (95% CI, 65.5–80.3) in the highest tertile (log-rank P =0.02). Each 1-SD increase in mean pulmonary arterial pressure was associated with 1.33-fold higher odds of in-hospital failure (adjusted odds ratio, 1.33 [95% CI, 1.00–1.77]; P =0.05) and a 2.2-fold higher hazard of death or transplantation (adjusted hazard ratio, 2.20 [95% CI, 1.62–3.00]; P P P 4 years of age versus 2 to 4 years of age; adjusted hazard ratio, 1.80 [95% CI, 1.25–2.60]; P =0.02). CONCLUSIONS: Elevated pre-Fontan mean pulmonary arterial pressure is a strong predictor of in-hospital and long-term post-Fontan risk of death or transplantation. Systemic right ventricle and delayed Fontan completion (>4 years of age) further increased risk. These findings support early Fontan consideration and ongoing hemodynamic surveillance to optimize long-term outcomes.
- 10 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (6) , 382-395
Top Cited PapersAssociation of Pre-Fontan Hemodynamics With Long-Term Outcomes After Fontan Palliation: A Study From the Pediatric Cardiac Care Consortium
BACKGROUND: Long-term outcomes after Fontan vary widely. Although pre-Fontan hemodynamics predict early failure, their association with long-term outcomes remains unclear. We hypothesized that pre-Fontan hemodynamics predict long-term risk of death or transplantation. METHODS: We analyzed data from the Pediatric Cardiac Care Consortium, a US-based multicenter registry including patients undergoing first-time Fontan with pre-Fontan catheterization and long-term follow-up. Patients undergoing a Fontan procedure before 18 years of age at any time between 1982 and 2011 were included in the study. Outcomes of interest were in-hospital Fontan failure (death or takedown) and postdischarge death or transplantation, identified through matching with the National Death Index and the Organ Procurement and Transplantation Network through 2022. Associations between pre-Fontan hemodynamics and long-term risk for death or transplantation were assessed with Kaplan-Meier survival curves and extended Cox regression. RESULTS: Among 1175 patients (736 [62.6%] male, 626 [53.3%] with systemic left ventricle), 1111 were discharged with Fontan physiology. Over a median postdischarge follow-up of 20.6 years (interquartile range, 18.2–24.4 years), 85 deaths and 49 transplantations occurred. Pre-Fontan mean pulmonary arterial pressure was the strongest hemodynamic predictor of postdischarge outcomes with a continuous association and no clear inflection point; 25-year transplantation-free survival declined from 83.7% (95% CI, 77.6–88.3) in the low mean pulmonary arterial pressure tertile to 73.7% (95% CI, 65.5–80.3) in the highest tertile (log-rank P =0.02). Each 1-SD increase in mean pulmonary arterial pressure was associated with 1.33-fold higher odds of in-hospital failure (adjusted odds ratio, 1.33 [95% CI, 1.00–1.77]; P =0.05) and a 2.2-fold higher hazard of death or transplantation (adjusted hazard ratio, 2.20 [95% CI, 1.62–3.00]; P P P 4 years of age versus 2 to 4 years of age; adjusted hazard ratio, 1.80 [95% CI, 1.25–2.60]; P =0.02). CONCLUSIONS: Elevated pre-Fontan mean pulmonary arterial pressure is a strong predictor of in-hospital and long-term post-Fontan risk of death or transplantation. Systemic right ventricle and delayed Fontan completion (>4 years of age) further increased risk. These findings support early Fontan consideration and ongoing hemodynamic surveillance to optimize long-term outcomes.
- 26 August 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (8) , 508-518
The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study
BACKGROUND: Fontan circulatory failure (FCF) is a chronic state in palliated single ventricle heart disease with high morbidity and mortality rates, including heart failure, multisystem end-organ disease, and need for heart transplant. Specific FCF morbidities have not been rigorously defined, limiting study of how FCF morbidities affect pre–heart transplant and post–heart transplant outcomes. We hypothesized that FCF-related morbidities affect survival from heart transplant waitlisting through 1 year after heart transplant. METHODS: This 20-center, retrospective cohort study collected demographic, medical/surgical history, waitlist, and peri- and post–heart transplant data, and a priori defined FCF-specific morbidities, in Fontan patients who were listed for heart transplant from 2008 through 2022. Univariate 2-group statistics compared surviving individuals with those who died anytime from waitlisting to 1 year after heart transplant, died on the waitlist, or underwent transplant and died within 1 year after transplant. Using covariates from both univariate analyses, multivariable logistic regression determined the primary study outcome of independent FCF risk factors for death between waitlist and 1 year after heart transplant. RESULTS: Of 409 waitlisted patients, 24 (5.9%) died on the waitlist. Of the 341 (83.4%) who underwent transplant, 27 (8.5%) did not survive to 1 year. Univariate risk factors for waitlist death included higher aortopulmonary collateral burden, >1 hospitalization in the previous year, younger age, sleep apnea, higher New York Heart Association class, nonenrollment in school or work, and single-parent home. Risk factors for 1-year post–heart transplant mortality included hypoplastic left heart syndrome diagnosis, patent fenestration, anatomic Fontan obstruction, clinical cyanosis (pulse oximetry 1 hospitalization in the year before waitlisting (adjusted odds ratio, 2.0 [95% CI, 1.0–4.1]; P =0.05) and clinical cyanosis (adjusted odds ratio, 5.0 [95% CI, 1.8–13.4]; P =0.002). CONCLUSIONS: Patients with Fontan palliation selected for heart transplant have substantial mortality rates from waitlisting through transplant. Among FCF-specific morbidities, cyanosis is associated with worsened survival and necessitates further study. Clinical morbidity of any type requiring repeated hospital admission also should prompt consideration of heart transplant.
- 26 August 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (8) , 508-518
The Impact of Fontan Circulatory Failure on Heart Transplant Survival: A 20-Center Retrospective Cohort Study
BACKGROUND: Fontan circulatory failure (FCF) is a chronic state in palliated single ventricle heart disease with high morbidity and mortality rates, including heart failure, multisystem end-organ disease, and need for heart transplant. Specific FCF morbidities have not been rigorously defined, limiting study of how FCF morbidities affect pre–heart transplant and post–heart transplant outcomes. We hypothesized that FCF-related morbidities affect survival from heart transplant waitlisting through 1 year after heart transplant. METHODS: This 20-center, retrospective cohort study collected demographic, medical/surgical history, waitlist, and peri- and post–heart transplant data, and a priori defined FCF-specific morbidities, in Fontan patients who were listed for heart transplant from 2008 through 2022. Univariate 2-group statistics compared surviving individuals with those who died anytime from waitlisting to 1 year after heart transplant, died on the waitlist, or underwent transplant and died within 1 year after transplant. Using covariates from both univariate analyses, multivariable logistic regression determined the primary study outcome of independent FCF risk factors for death between waitlist and 1 year after heart transplant. RESULTS: Of 409 waitlisted patients, 24 (5.9%) died on the waitlist. Of the 341 (83.4%) who underwent transplant, 27 (8.5%) did not survive to 1 year. Univariate risk factors for waitlist death included higher aortopulmonary collateral burden, >1 hospitalization in the previous year, younger age, sleep apnea, higher New York Heart Association class, nonenrollment in school or work, and single-parent home. Risk factors for 1-year post–heart transplant mortality included hypoplastic left heart syndrome diagnosis, patent fenestration, anatomic Fontan obstruction, clinical cyanosis (pulse oximetry 1 hospitalization in the year before waitlisting (adjusted odds ratio, 2.0 [95% CI, 1.0–4.1]; P =0.05) and clinical cyanosis (adjusted odds ratio, 5.0 [95% CI, 1.8–13.4]; P =0.002). CONCLUSIONS: Patients with Fontan palliation selected for heart transplant have substantial mortality rates from waitlisting through transplant. Among FCF-specific morbidities, cyanosis is associated with worsened survival and necessitates further study. Clinical morbidity of any type requiring repeated hospital admission also should prompt consideration of heart transplant.
- 22 July 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (4) , 1696-1706
Relationship Between Central Venous Pressure, Cardiac Index, and Renal Function in Pediatric Heart Failure: a Pediatric Heart Transplant Society Study
Renal dysfunction (RD) is common in patients with heart failure with or without congenital heart disease, but the determinants of renal dysfunction are not well understood in children with heart failure. Low cardiac output is often discussed as a risk factor for RD. The purpose of this study was therefore to elucidate the relationship between renal function and hemodynamic parameters in children with heart failure. Children (age < 18, n = 3739) listed for HT in the PHTS database from 1993–2023 were included. Laboratory, clinical, hemodynamic, and demographic parameters were collected and analyzed for the study. RD was defined as eGFR less than 40 ml/min/1.73 m2 for patients younger than 2 years old, less than 60 ml/min/1.73 m2 for patients 2 years old and older. We assessed correlation between eGFR and hemodynamic parameters. Logistic regression was used to assess risk factors for renal dysfunction by etiologic cohort. The mean age was 7.2 ± 6.2 years, weight 27.78 ± 25.03 kg, male gender 58%, 39% with cardiomyopathy (CM) and 61% with congenital heart disease (CHD) including 21% with Fontan circulation. RD was present in 6% of the cohort. In CM cohort, high BMI (OR 1.057, 1.025–1.091), male gender (OR 2.08, 1.21–3.59), black race (OR 1.98, 1.17–3.36) and heart failure category of high cardiac index with high CVP compared to high cardiac index with low CVP (OR 2.34, 1.27–4.29) were significant predictors of renal dysfunction. In Fontan cohort, only BMI (OR 1.08, CI 1.023–1.134) was associated with renal dysfunction while none of the hemodynamic parameters predicted RD in CHD cohort. Lastly, RD at listing (OR 2.82, CI 1.50–5.28), weight at transplant (OR 1.00, CI 1.00–1.01), post-transplant mechanical circulatory support (OR 2.55, CI 1.04–6.26), and post-transplant dialysis (2.74, CI 1.106.84) were associated with RD at one-year post-transplant for the overall cohort. The relationship between various clinical and hemodynamic factors and renal dysfunction is complex in children with heart failure. Further, the study continued to show persistent impact of renal dysfunction at listing on post-transplant renal function. Improving understanding modifiable risk factors by type of heart disease as well as role of newer heart failure therapies is critical in reducing this significant morbidity.
- 22 July 2025
- Published by Springer Nature in Pediatric Cardiology
- Vol. 47 (4) , 1696-1706
Relationship Between Central Venous Pressure, Cardiac Index, and Renal Function in Pediatric Heart Failure: a Pediatric Heart Transplant Society Study
Renal dysfunction (RD) is common in patients with heart failure with or without congenital heart disease, but the determinants of renal dysfunction are not well understood in children with heart failure. Low cardiac output is often discussed as a risk factor for RD. The purpose of this study was therefore to elucidate the relationship between renal function and hemodynamic parameters in children with heart failure. Children (age < 18, n = 3739) listed for HT in the PHTS database from 1993–2023 were included. Laboratory, clinical, hemodynamic, and demographic parameters were collected and analyzed for the study. RD was defined as eGFR less than 40 ml/min/1.73 m2 for patients younger than 2 years old, less than 60 ml/min/1.73 m2 for patients 2 years old and older. We assessed correlation between eGFR and hemodynamic parameters. Logistic regression was used to assess risk factors for renal dysfunction by etiologic cohort. The mean age was 7.2 ± 6.2 years, weight 27.78 ± 25.03 kg, male gender 58%, 39% with cardiomyopathy (CM) and 61% with congenital heart disease (CHD) including 21% with Fontan circulation. RD was present in 6% of the cohort. In CM cohort, high BMI (OR 1.057, 1.025–1.091), male gender (OR 2.08, 1.21–3.59), black race (OR 1.98, 1.17–3.36) and heart failure category of high cardiac index with high CVP compared to high cardiac index with low CVP (OR 2.34, 1.27–4.29) were significant predictors of renal dysfunction. In Fontan cohort, only BMI (OR 1.08, CI 1.023–1.134) was associated with renal dysfunction while none of the hemodynamic parameters predicted RD in CHD cohort. Lastly, RD at listing (OR 2.82, CI 1.50–5.28), weight at transplant (OR 1.00, CI 1.00–1.01), post-transplant mechanical circulatory support (OR 2.55, CI 1.04–6.26), and post-transplant dialysis (2.74, CI 1.106.84) were associated with RD at one-year post-transplant for the overall cohort. The relationship between various clinical and hemodynamic factors and renal dysfunction is complex in children with heart failure. Further, the study continued to show persistent impact of renal dysfunction at listing on post-transplant renal function. Improving understanding modifiable risk factors by type of heart disease as well as role of newer heart failure therapies is critical in reducing this significant morbidity.
- Open Access
- 18 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102570
Cardiac Catheterization and Interventions in Pediatric Patients on ECMO: Analysis of the IMPACT Registry
- 18 March 2025
- Published by Elsevier in Journal of the Society for Cardiovascular Angiography & Interventions
- Vol. 4 (3) , 102570
Open AccessCardiac Catheterization and Interventions in Pediatric Patients on ECMO: Analysis of the IMPACT Registry
- 3 February 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (3) , 513-519
Unexpected cardiac interventions including takedown after Glenn surgery: analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database
Background: Glenn procedure carries low morbidity and mortality within stages of single-ventricle palliation. However, some patients with Glenn failure need a stage reversal, while others require unanticipated surgical interventions. Our understanding of perioperative factors and outcomes associated with such unexpected interventions is extremely limited.Methods: Patients who underwent unexpected surgery after the Glenn procedure between January 2010 and December 2019 within the Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) were identified with a subgroup analysis of those reverting to stage I physiology. Patient’s requiring reversal to stage I palliation were matched 1:5 with controls. Multivariable logistic regression analysis was performed to evaluate risk factors for reintervention.Results: A total of 16,913 patients underwent Glenn procedure with 1221 (7.2%) requiring unexpected cardiac surgical intervention and 95 (0.56%) patients required takedown to a stage I. Significant clinical and operative risk factors were identified for such unexpected interventions.The overall mortality after Glenn procedure was 1.2%, while mortality after unexpected reintervention was 6.6% at 30 days and after Glenn takedown was 27.5% at last follow-up. Unexpected surgical intervention and right ventricular dominance were significant risk factors for mortality.Conclusion: Unexpected reinterventions, including need for takedown after the Glenn procedure, are associated with significantly higher mortality. Further studies should focus on improving our patient selection, understanding the risk factors mechanistically, including impact of the right ventricle as systemic ventricle in order to avoid need for unexpected surgical interventions.
- 3 February 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (3) , 513-519
Unexpected cardiac interventions including takedown after Glenn surgery: analysis of the Society of Thoracic Surgeons Congenital Heart Surgery Database
Background: Glenn procedure carries low morbidity and mortality within stages of single-ventricle palliation. However, some patients with Glenn failure need a stage reversal, while others require unanticipated surgical interventions. Our understanding of perioperative factors and outcomes associated with such unexpected interventions is extremely limited.Methods: Patients who underwent unexpected surgery after the Glenn procedure between January 2010 and December 2019 within the Society of Thoracic Surgeons Congenital Heart Surgery Database (STS-CHSD) were identified with a subgroup analysis of those reverting to stage I physiology. Patient’s requiring reversal to stage I palliation were matched 1:5 with controls. Multivariable logistic regression analysis was performed to evaluate risk factors for reintervention.Results: A total of 16,913 patients underwent Glenn procedure with 1221 (7.2%) requiring unexpected cardiac surgical intervention and 95 (0.56%) patients required takedown to a stage I. Significant clinical and operative risk factors were identified for such unexpected interventions.The overall mortality after Glenn procedure was 1.2%, while mortality after unexpected reintervention was 6.6% at 30 days and after Glenn takedown was 27.5% at last follow-up. Unexpected surgical intervention and right ventricular dominance were significant risk factors for mortality.Conclusion: Unexpected reinterventions, including need for takedown after the Glenn procedure, are associated with significantly higher mortality. Further studies should focus on improving our patient selection, understanding the risk factors mechanistically, including impact of the right ventricle as systemic ventricle in order to avoid need for unexpected surgical interventions.
- 17 January 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (2) , 303-310
Racial disparities in timing and outcomes for patients undergoing staged single ventricle palliation: a single institution report
Background: Racial disparities in healthcare have been well documented in the United States. We hypothesise that there will be a racial variance in different clinical variables in single-ventricle patients through stages of palliation.Materials and Methods: Retrospective single-centre study stratified all single-ventricle patients who reached stage 2 palliation by race: Black and White. Other races were excluded. Demographic and clinical characteristics were compared, alongside follow-up survival data. Primary outcomes were progression to Fontan and overall survival.Results: Among 526 patients, 325 (61.8%) were White, and 201 (38.2%) were Black. Median age at stage 2 palliation was 150 days for White and 165 for Black patients (p = 0.005), with similar weights. Black patients exhibited higher median cardiopulmonary bypass times (87 vs. 74 minutes, p = 0.001) and a greater frequency of genetic syndromes (30.1% vs. 22.1%, p = 0.044). No significant differences were observed in outcomes between groups from stage 2 to stage 3, pre-stage 3 cardiac catheterisation variables, or perioperative outcomes. Multivariable regression analysis identified hypoplastic pulmonary arteries as the risk factor for mortality after stage 2. Survival analysis showed no difference in survival by race; however, occurrence of combined cardiovascular event was significantly higher in Black race.Conclusions: Significant racial disparities exist among single-ventricle patients regarding the timing of stage 2 palliation, cardiopulmonary bypass duration, and frequency of genetic syndromes. Black race was a risk factor for sub-optimal long-term outcome, although perioperative mortality was similar. These race-related factors warrant further studies to improve our understanding of the impact of race on outcomes.
- 17 January 2025
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 35 (2) , 303-310
Racial disparities in timing and outcomes for patients undergoing staged single ventricle palliation: a single institution report
Background: Racial disparities in healthcare have been well documented in the United States. We hypothesise that there will be a racial variance in different clinical variables in single-ventricle patients through stages of palliation.Materials and Methods: Retrospective single-centre study stratified all single-ventricle patients who reached stage 2 palliation by race: Black and White. Other races were excluded. Demographic and clinical characteristics were compared, alongside follow-up survival data. Primary outcomes were progression to Fontan and overall survival.Results: Among 526 patients, 325 (61.8%) were White, and 201 (38.2%) were Black. Median age at stage 2 palliation was 150 days for White and 165 for Black patients (p = 0.005), with similar weights. Black patients exhibited higher median cardiopulmonary bypass times (87 vs. 74 minutes, p = 0.001) and a greater frequency of genetic syndromes (30.1% vs. 22.1%, p = 0.044). No significant differences were observed in outcomes between groups from stage 2 to stage 3, pre-stage 3 cardiac catheterisation variables, or perioperative outcomes. Multivariable regression analysis identified hypoplastic pulmonary arteries as the risk factor for mortality after stage 2. Survival analysis showed no difference in survival by race; however, occurrence of combined cardiovascular event was significantly higher in Black race.Conclusions: Significant racial disparities exist among single-ventricle patients regarding the timing of stage 2 palliation, cardiopulmonary bypass duration, and frequency of genetic syndromes. Black race was a risk factor for sub-optimal long-term outcome, although perioperative mortality was similar. These race-related factors warrant further studies to improve our understanding of the impact of race on outcomes.
- 24 June 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (1)
Outcomes of heart transplantation in children with previously palliated hypoplastic left heart syndrome
OBJECTIVES: Paediatric heart transplantation in children who fail multistage palliation for hypoplastic left heart syndrome is associated with challenges related to immune, clinical or anatomic risk factors. We review current outcomes and risk factors for survival following heart transplantation in this challenging patient population. METHODS: The United Network for Organ Sharing transplantation database was merged with Paediatric Health Information System database to identify children who received heart transplantation following prior palliation for hypoplastic left heart syndrome. Multivariable Cox analysis of outcomes and factors affecting survival was performed. RESULTS: Our cohort included 849 children between 2009 and 2021. The median age was 1044 days (interquartile range 108–3535), and the median weight was 13 kg (interquartile range 7–26). Overall survival at 10 years following heart transplantation was 71%, with most of the death being perioperative. On multivariable analysis, risk factors for survival included Black race (hazard ratio = 1.630, P = 0.0253), blood type other than B (hazard ratio = 2.564, P = 0.0052) and male donor gender (hazard ratio = 1.367, P = 0.0483). Recipient age, the use of ventricular assist device or extracorporeal membrane oxygenation were not significantly associated with survival. Twenty-four patients underwent retransplantation, and 10-year freedom from retransplantation was 98%. Rejection before hospital discharge and within 1 year from transplantation was 20% and 24%, respectively, with infants having lower rejection rates. CONCLUSIONS: Compared with existing literature, the number of children with prior hypoplastic left heart syndrome palliation who receive heart transplantation has increased in the current era. Survival following transplantation in this patient population is acceptable. Most of the death is perioperative. Efforts to properly support these patients before transplantation might decrease early mortality and improve overall survival.
- 24 June 2024
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 66 (1)
Outcomes of heart transplantation in children with previously palliated hypoplastic left heart syndrome
OBJECTIVES: Paediatric heart transplantation in children who fail multistage palliation for hypoplastic left heart syndrome is associated with challenges related to immune, clinical or anatomic risk factors. We review current outcomes and risk factors for survival following heart transplantation in this challenging patient population. METHODS: The United Network for Organ Sharing transplantation database was merged with Paediatric Health Information System database to identify children who received heart transplantation following prior palliation for hypoplastic left heart syndrome. Multivariable Cox analysis of outcomes and factors affecting survival was performed. RESULTS: Our cohort included 849 children between 2009 and 2021. The median age was 1044 days (interquartile range 108–3535), and the median weight was 13 kg (interquartile range 7–26). Overall survival at 10 years following heart transplantation was 71%, with most of the death being perioperative. On multivariable analysis, risk factors for survival included Black race (hazard ratio = 1.630, P = 0.0253), blood type other than B (hazard ratio = 2.564, P = 0.0052) and male donor gender (hazard ratio = 1.367, P = 0.0483). Recipient age, the use of ventricular assist device or extracorporeal membrane oxygenation were not significantly associated with survival. Twenty-four patients underwent retransplantation, and 10-year freedom from retransplantation was 98%. Rejection before hospital discharge and within 1 year from transplantation was 20% and 24%, respectively, with infants having lower rejection rates. CONCLUSIONS: Compared with existing literature, the number of children with prior hypoplastic left heart syndrome palliation who receive heart transplantation has increased in the current era. Survival following transplantation in this patient population is acceptable. Most of the death is perioperative. Efforts to properly support these patients before transplantation might decrease early mortality and improve overall survival.
- 17 June 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 118 (4) , 897-898
Pediatric Ventricular Assist Device–Related Stroke and Outcomes: Factor in the Patient
- 17 June 2024
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 118 (4) , 897-898
Pediatric Ventricular Assist Device–Related Stroke and Outcomes: Factor in the Patient